drug

parathyroid hormone

1 story · latest Jul 22, 2026

Status: FDA approved Jan 2015 · BLA125511
Brand: Natpara

Timeline

FDA accepts BridgeBio's NDA for encaleret in ADH1

Jul 22Regulatory milestoneBridgeBio Pharma, Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.